CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial ResultsGlobeNewsWire • 07/27/20
Will CRISPR Therapeutics AG (CRSP) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/27/20
Where to Invest $1,000 If You're Worried the Stock Market Might Crash AgainThe Motley Fool • 06/21/20
CRISPR Rally: The First Gene-Editing Drug Continues To Show PromiseInvestors Business Daily • 06/12/20
CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) CongressGlobeNewsWire • 06/12/20
Why Is CRISPR Therapeutics AG (CRSP) Up 22.9% Since Last Earnings Report?Zacks Investment Research • 05/28/20
Stocks Showing Market Leadership: CRISPR Therapeutics Earns 92 RS RatingInvestors Business Daily • 05/18/20